nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.118	0.332	CbGbCtD
Clindamycin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.109	0.308	CbGbCtD
Clindamycin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0503	0.142	CbGbCtD
Clindamycin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.046	0.13	CbGbCtD
Clindamycin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0314	0.0885	CbGbCtD
Clindamycin—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000477	0.00074	CcSEcCtD
Clindamycin—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000739	CcSEcCtD
Clindamycin—Flushing—Etoposide—peripheral nervous system neoplasm	0.000473	0.000733	CcSEcCtD
Clindamycin—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000473	0.000733	CcSEcCtD
Clindamycin—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000466	0.000722	CcSEcCtD
Clindamycin—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000464	0.000719	CcSEcCtD
Clindamycin—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000455	0.000705	CcSEcCtD
Clindamycin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.000704	CcSEcCtD
Clindamycin—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000451	0.000699	CcSEcCtD
Clindamycin—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000451	0.000699	CcSEcCtD
Clindamycin—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000448	0.000694	CcSEcCtD
Clindamycin—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000447	0.000693	CcSEcCtD
Clindamycin—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000445	0.00069	CcSEcCtD
Clindamycin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000443	0.000686	CcSEcCtD
Clindamycin—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000684	CcSEcCtD
Clindamycin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000439	0.000681	CcSEcCtD
Clindamycin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000439	0.000681	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000678	CcSEcCtD
Clindamycin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000438	0.000678	CcSEcCtD
Clindamycin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000437	0.000677	CcSEcCtD
Clindamycin—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000434	0.000673	CcSEcCtD
Clindamycin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000433	0.000672	CcSEcCtD
Clindamycin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000433	0.000672	CcSEcCtD
Clindamycin—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.000672	CcSEcCtD
Clindamycin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000433	0.000671	CcSEcCtD
Clindamycin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000433	0.000671	CcSEcCtD
Clindamycin—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000432	0.00067	CcSEcCtD
Clindamycin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000431	0.000669	CcSEcCtD
Clindamycin—Back pain—Etoposide—peripheral nervous system neoplasm	0.000429	0.000665	CcSEcCtD
Clindamycin—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000428	0.000663	CcSEcCtD
Clindamycin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000427	0.000663	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000661	CcSEcCtD
Clindamycin—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000427	0.000661	CcSEcCtD
Clindamycin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000422	0.000654	CcSEcCtD
Clindamycin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000419	0.000649	CcSEcCtD
Clindamycin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000419	0.000649	CcSEcCtD
Clindamycin—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000418	0.000647	CcSEcCtD
Clindamycin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.000641	CcSEcCtD
Clindamycin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000413	0.000641	CcSEcCtD
Clindamycin—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00041	0.000636	CcSEcCtD
Clindamycin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000409	0.000634	CcSEcCtD
Clindamycin—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000408	0.000633	CcSEcCtD
Clindamycin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000408	0.000632	CcSEcCtD
Clindamycin—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000407	0.000631	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000628	CcSEcCtD
Clindamycin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000405	0.000627	CcSEcCtD
Clindamycin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000405	0.000627	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.0004	0.000621	CcSEcCtD
Clindamycin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.0004	0.00062	CcSEcCtD
Clindamycin—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.00062	CcSEcCtD
Clindamycin—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000399	0.000618	CcSEcCtD
Clindamycin—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000397	0.000616	CcSEcCtD
Clindamycin—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.000615	CcSEcCtD
Clindamycin—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000397	0.000615	CcSEcCtD
Clindamycin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000395	0.000613	CcSEcCtD
Clindamycin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000395	0.000613	CcSEcCtD
Clindamycin—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000395	0.000613	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000612	CcSEcCtD
Clindamycin—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000609	CcSEcCtD
Clindamycin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000392	0.000608	CcSEcCtD
Clindamycin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000389	0.000603	CcSEcCtD
Clindamycin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000389	0.000603	CcSEcCtD
Clindamycin—Rash—Topotecan—peripheral nervous system neoplasm	0.000389	0.000603	CcSEcCtD
Clindamycin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000389	0.000602	CcSEcCtD
Clindamycin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000387	0.0006	CcSEcCtD
Clindamycin—Headache—Topotecan—peripheral nervous system neoplasm	0.000387	0.000599	CcSEcCtD
Clindamycin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.000598	CcSEcCtD
Clindamycin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000386	0.000598	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000386	0.000598	CcSEcCtD
Clindamycin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000386	0.000598	CcSEcCtD
Clindamycin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.000598	CcSEcCtD
Clindamycin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000385	0.000597	CcSEcCtD
Clindamycin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000384	0.000595	CcSEcCtD
Clindamycin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000383	0.000594	CcSEcCtD
Clindamycin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000383	0.000594	CcSEcCtD
Clindamycin—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000383	0.000594	CcSEcCtD
Clindamycin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000382	0.000592	CcSEcCtD
Clindamycin—Pain—Vincristine—peripheral nervous system neoplasm	0.000382	0.000592	CcSEcCtD
Clindamycin—Rash—Melphalan—peripheral nervous system neoplasm	0.000381	0.00059	CcSEcCtD
Clindamycin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000381	0.00059	CcSEcCtD
Clindamycin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000379	0.000588	CcSEcCtD
Clindamycin—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000587	CcSEcCtD
Clindamycin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000585	CcSEcCtD
Clindamycin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000373	0.000578	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000576	CcSEcCtD
Clindamycin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000369	0.000572	CcSEcCtD
Clindamycin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000369	0.000571	CcSEcCtD
Clindamycin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000368	0.000571	CcSEcCtD
Clindamycin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.000568	CcSEcCtD
Clindamycin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.000568	CcSEcCtD
Clindamycin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000366	0.000568	CcSEcCtD
Clindamycin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000366	0.000567	CcSEcCtD
Clindamycin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000364	0.000564	CcSEcCtD
Clindamycin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000364	0.000564	CcSEcCtD
Clindamycin—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000563	CcSEcCtD
Clindamycin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000362	0.000561	CcSEcCtD
Clindamycin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000557	CcSEcCtD
Clindamycin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000359	0.000556	CcSEcCtD
Clindamycin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000359	0.000556	CcSEcCtD
Clindamycin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000355	0.000549	CcSEcCtD
Clindamycin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000548	CcSEcCtD
Clindamycin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000353	0.000548	CcSEcCtD
Clindamycin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000353	0.000548	CcSEcCtD
Clindamycin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000352	0.000546	CcSEcCtD
Clindamycin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000543	CcSEcCtD
Clindamycin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000541	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000533	CcSEcCtD
Clindamycin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000342	0.000531	CcSEcCtD
Clindamycin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000342	0.00053	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000341	0.000529	CcSEcCtD
Clindamycin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000338	0.000524	CcSEcCtD
Clindamycin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000338	0.000524	CcSEcCtD
Clindamycin—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000517	CcSEcCtD
Clindamycin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000517	CcSEcCtD
Clindamycin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000333	0.000516	CcSEcCtD
Clindamycin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000515	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000514	CcSEcCtD
Clindamycin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000329	0.00051	CcSEcCtD
Clindamycin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000328	0.000509	CcSEcCtD
Clindamycin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000507	CcSEcCtD
Clindamycin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000505	CcSEcCtD
Clindamycin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000323	0.0005	CcSEcCtD
Clindamycin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000321	0.000497	CcSEcCtD
Clindamycin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000318	0.000493	CcSEcCtD
Clindamycin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000317	0.000492	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000489	CcSEcCtD
Clindamycin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000315	0.000489	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000313	0.000485	CcSEcCtD
Clindamycin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000312	0.000484	CcSEcCtD
Clindamycin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000312	0.000484	CcSEcCtD
Clindamycin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000481	CcSEcCtD
Clindamycin—Pain—Etoposide—peripheral nervous system neoplasm	0.00031	0.00048	CcSEcCtD
Clindamycin—Constipation—Etoposide—peripheral nervous system neoplasm	0.00031	0.00048	CcSEcCtD
Clindamycin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000479	CcSEcCtD
Clindamycin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000479	CcSEcCtD
Clindamycin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000479	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000476	CcSEcCtD
Clindamycin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000307	0.000475	CcSEcCtD
Clindamycin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000306	0.000474	CcSEcCtD
Clindamycin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000467	CcSEcCtD
Clindamycin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000465	CcSEcCtD
Clindamycin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000297	0.000461	CcSEcCtD
Clindamycin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000297	0.00046	CcSEcCtD
Clindamycin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000296	0.000459	CcSEcCtD
Clindamycin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000296	0.000458	CcSEcCtD
Clindamycin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000295	0.000457	CcSEcCtD
Clindamycin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.000453	CcSEcCtD
Clindamycin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.000453	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000452	CcSEcCtD
Clindamycin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000291	0.000451	CcSEcCtD
Clindamycin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000291	0.00045	CcSEcCtD
Clindamycin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000288	0.000446	CcSEcCtD
Clindamycin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000445	CcSEcCtD
Clindamycin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000286	0.000444	CcSEcCtD
Clindamycin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000286	0.000444	CcSEcCtD
Clindamycin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000444	CcSEcCtD
Clindamycin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000284	0.000441	CcSEcCtD
Clindamycin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000284	0.00044	CcSEcCtD
Clindamycin—Rash—Vincristine—peripheral nervous system neoplasm	0.000282	0.000437	CcSEcCtD
Clindamycin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000282	0.000436	CcSEcCtD
Clindamycin—Headache—Vincristine—peripheral nervous system neoplasm	0.00028	0.000434	CcSEcCtD
Clindamycin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.00043	CcSEcCtD
Clindamycin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.000427	CcSEcCtD
Clindamycin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000426	CcSEcCtD
Clindamycin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00027	0.000419	CcSEcCtD
Clindamycin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000419	CcSEcCtD
Clindamycin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000267	0.000413	CcSEcCtD
Clindamycin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000265	0.000412	CcSEcCtD
Clindamycin—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000411	CcSEcCtD
Clindamycin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00026	0.000403	CcSEcCtD
Clindamycin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000256	0.000397	CcSEcCtD
Clindamycin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000251	0.00039	CcSEcCtD
Clindamycin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000387	CcSEcCtD
Clindamycin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000249	0.000386	CcSEcCtD
Clindamycin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000249	0.000386	CcSEcCtD
Clindamycin—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000385	CcSEcCtD
Clindamycin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000248	0.000384	CcSEcCtD
Clindamycin—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.00038	CcSEcCtD
Clindamycin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000245	0.00038	CcSEcCtD
Clindamycin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000377	CcSEcCtD
Clindamycin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000373	CcSEcCtD
Clindamycin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000239	0.000371	CcSEcCtD
Clindamycin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000371	CcSEcCtD
Clindamycin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000235	0.000364	CcSEcCtD
Clindamycin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00023	0.000357	CcSEcCtD
Clindamycin—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000357	CcSEcCtD
Clindamycin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000356	CcSEcCtD
Clindamycin—Rash—Etoposide—peripheral nervous system neoplasm	0.000228	0.000354	CcSEcCtD
Clindamycin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000228	0.000354	CcSEcCtD
Clindamycin—Headache—Etoposide—peripheral nervous system neoplasm	0.000227	0.000352	CcSEcCtD
Clindamycin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000351	CcSEcCtD
Clindamycin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000349	CcSEcCtD
Clindamycin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000346	CcSEcCtD
Clindamycin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000345	CcSEcCtD
Clindamycin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000345	CcSEcCtD
Clindamycin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000343	CcSEcCtD
Clindamycin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000215	0.000333	CcSEcCtD
Clindamycin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000333	CcSEcCtD
Clindamycin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.00033	CcSEcCtD
Clindamycin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000324	CcSEcCtD
Clindamycin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00032	CcSEcCtD
Clindamycin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000319	CcSEcCtD
Clindamycin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000315	CcSEcCtD
Clindamycin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000308	CcSEcCtD
Clindamycin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000308	CcSEcCtD
Clindamycin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.0003	CcSEcCtD
Clindamycin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000294	CcSEcCtD
Clindamycin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000291	CcSEcCtD
Clindamycin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000285	CcSEcCtD
Clindamycin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000181	0.00028	CcSEcCtD
Clindamycin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000277	CcSEcCtD
Clindamycin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000272	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000272	CcSEcCtD
Clindamycin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000271	CcSEcCtD
Clindamycin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000269	CcSEcCtD
Clindamycin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000269	CcSEcCtD
Clindamycin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.00026	CcSEcCtD
Clindamycin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000257	CcSEcCtD
Clindamycin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000256	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000251	CcSEcCtD
Clindamycin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000251	CcSEcCtD
Clindamycin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000161	0.00025	CcSEcCtD
Clindamycin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000249	CcSEcCtD
Clindamycin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000249	CcSEcCtD
Clindamycin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000249	CcSEcCtD
Clindamycin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000249	CcSEcCtD
Clindamycin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000238	CcSEcCtD
Clindamycin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000232	CcSEcCtD
Clindamycin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000231	CcSEcCtD
Clindamycin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00023	CcSEcCtD
Clindamycin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00023	CcSEcCtD
Clindamycin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000226	CcSEcCtD
Clindamycin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000223	CcSEcCtD
Clindamycin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000215	CcSEcCtD
Clindamycin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000214	CcSEcCtD
Clindamycin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000209	CcSEcCtD
Clindamycin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000208	CcSEcCtD
Clindamycin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000206	CcSEcCtD
Clindamycin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000129	0.0002	CcSEcCtD
Clindamycin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000199	CcSEcCtD
Clindamycin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000198	CcSEcCtD
Clindamycin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000198	CcSEcCtD
Clindamycin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000197	CcSEcCtD
Clindamycin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000192	CcSEcCtD
Clindamycin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000187	CcSEcCtD
Clindamycin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000185	CcSEcCtD
Clindamycin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000184	CcSEcCtD
Clindamycin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000183	CcSEcCtD
Clindamycin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000182	CcSEcCtD
Clindamycin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000173	CcSEcCtD
